ReviewCancers2024

Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis.

Nicolas Girard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.